Correction to: Nature https://doi.org/10.1038/s41586-024-07461-6 Published online 22 May 2024
In the version of the article initially published, in Fig. 1e, both labels now reading “EDG” originally read “EWG”, and in Fig. 3b, both labels now reading “mFS” originally read “pFS”. The errors have been corrected in the HTML and PDF versions of the article. Additionally, the Supplementary Information has been updated to correct Supplementary Fig. 31. During pre-acceptance adjustments to text labels in the figures, the authors inadvertently copied the images of the LNCaP tumours (from Supplementary Fig. 30a) into the panel of Supplementary Fig. 31 where the 22RV1 tumour images should have been. The editors confirm that the distinct 22RV1 tumour images were present in prior, peer-reviewed versions of the manuscript, and these 22RV1 tumour images have now been reinstated in Supplementary Fig. 31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cui, XY., Li, Z., Kong, Z. et al. Publisher Correction: Covalent targeted radioligands potentiate radionuclide therapy. Nature 649, E9 (2026). https://doi.org/10.1038/s41586-025-09982-0
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41586-025-09982-0